{"nct_id":"NCT02465528","title":"Ceritinib Rare Indications Study in ALK+ Tumors","status":"TERMINATED","status_verified_date":"2019-12","start_date":"2016-05-06","start_date_type":"ACTUAL","primary_completion_date":"2018-08-20","primary_completion_date_type":"ACTUAL","completion_date":"2018-08-20","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}